Core Insights - Portolan Capital Management significantly increased its stake in Cellebrite DI Ltd. by acquiring 1,407,818 shares for approximately $28.65 million as of November 13, 2025 [2][3] - Following this transaction, Portolan's total ownership in Cellebrite reached 2,419,662 shares valued at $44.84 million, representing about 2.4% of its reportable assets under management (AUM) [3][6] - Cellebrite's stock price as of November 12, 2025, was $15.97, reflecting a 14% decline over the past year, underperforming the S&P 500 by 27 percentage points [4][5] Company Overview - Cellebrite specializes in digital intelligence solutions, providing services to law enforcement and enterprise clients for complex investigations [8][10] - The company generates revenue through proprietary software platforms and related services, facilitating legally sanctioned investigations across various digital devices and data sources [10] - Key financial metrics for Cellebrite include a total revenue of $455.90 million and a net income of $76.33 million for the trailing twelve months (TTM) [5]